2-fluoro-5-maleimidobenzoic acid-linked albumin drug (MAD) delivery for selective systemic targeting of metastatic prostate cancer

Tekijä Akinboye, Emmanuel S., Rogers, Oliver C., Isaacs, John T.
Julkaisussa Prostate (2018)

mRhubarb: Engineering of monomeric, red-shifted, and brighter variants of iRFP using structure-guided multi-site mutagenesis

Tekijä Rogers, Oliver C., Johnson, Dorothy M., Firnberg, Elad
Julkaisussa Sci Rep (2019)

PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer

Tekijä Rogers, Oliver C., Anthony, Lizamma, Rosen, D. Marc, Brennen, W. Nathaniel, Denmeade, Samuel R.
Julkaisussa Oncotarget (2018)

Microparticle Encapsulation of a Prostate-Targeted Biologic for the Treatment of Liver Metastases in a Preclinical Model of Castration-Resistant Prostate Cancer

Tekijä Rogers, Oliver C., Antony, Lizamma, Levy, Oren, Joshi, Nitin, Simons, Brian W., Dalrymple, Susan L., Rosen, D. Marc, Pickering, Andrew, Lan, Haoyue, Kuang, Heidi, Ranganath, Sudhir, Zheng, Lei, Karp, Jeffrey M., Howard, S. Peter, Denmeade, Samuel R., Isaacs, John T., Brennen, W. Nathaniel
Julkaisussa Mol Cancer Ther (2020)